Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives
Hematology Reports · 28.03.2025 · 17 (2) · 18
DOI: 10.3390/hematolrep17020018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology Reports, online erschienen am 28.03.2025. Verfasst von Laras Pratiwi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leukemia is a heterogeneous group of hematologic malignancies characterized by distinct genetic and molecular abnormalities. Advancements in genomic technologies have significantly transformed the diagnosis, prognosis, and treatment strategies for leukemia. Among these, next-generation sequencing (NGS) has emerged as a powerful tool, enabling high-resolution genomic profiling that surpasses conventional diagnostic approaches. By providing comprehensive insights into genetic mutations, clonal evolution, and resistance mechanisms, NGS has revolutionized precision medicine in leukemia management. Despite its transformative potential, the clinical integration of NGS presents challenges, including data interpretation complexities, standardization issues, and cost considerations. However, continuous advancements in sequencing platforms and bioinformatics pipelines are enhancing the reliability and accessibility of NGS in routine clinical practice. The expanding role of NGS in leukemia is paving the way for improved risk stratification, targeted therapies, and real-time disease monitoring, ultimately leading to better patient outcomes. This review highlights the impact of NGS on leukemia research and clinical applications, discussing its advantages over traditional diagnostic techniques, key sequencing approaches, and emerging challenges. As precision oncology continues to evolve, NGS is expected to play an increasingly central role in the diagnosis and management of leukemia, driving innovations in personalized medicine and therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.
- Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya 60286, Indonesia.
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.
- Department of Internal Medicine, Airlangga University Hospital, Surabaya 60115, Indonesia.
ORCID-Profile: Henry Sutanto
Zitieren
APA
Pratiwi, L., Mashudi, F. H., Ningtyas, M. C., Sutanto, H., & Romadhon, P. Z. (2025). Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives. Hematology Reports, 17(2), 18. https://doi.org/10.3390/hematolrep17020018
Vancouver
Pratiwi L, Mashudi FH, Ningtyas MC, Sutanto H, Romadhon PZ. Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives. Hematology Reports. 2025;17(2):18. doi:10.3390/hematolrep17020018
BibTeX
@article{Pratiwi2025,
author = {Pratiwi, Laras and Mashudi, Fawzia Hanum and Ningtyas, Mukti Citra and Sutanto, Henry and Romadhon, Pradana Zaky},
title = {Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives},
journal = {Hematology Reports},
year = {2025},
volume = {17},
number = {2},
pages = {18},
doi = {10.3390/hematolrep17020018}
}
EUVIMED